Disease Site Teams
DISEASE SITE TEAMS
Your best chance at beating cancer is at a comprehensive cancer center that features teams of specialists working together in the same facility where state-of-the-art cancer treatment is given, and relevant research is conducted.
Our multidisciplinary care teams include specialists from each diagnostic, treatment and supportive care discipline including surgery, hematology and medical oncology; radiation oncology; pathology; radiology; oncology, patient navigation, clinical research, nursing; supportive care; and, when appropriate, genetics.
The teams consist of physicians, nurses, therapists, social workers, dieticians and others and are each designed and staffed specifically to ensure that patients and their families get their cancer diagnosis and treatment right the first time.
COLORECTAL MDC TEAM
Colorectal cancer is one of the most preventable, treatable and beatable cancers. Although colorectal cancer is the third most common cause of cancer in the United States, more than 90 percent of colorectal cancers can be cured when caught in their earliest stages. Early detection is key.
Mary Bird Perkins – Our Lady of the Lake Cancer Center has a team approach to the prevention and treatment of colorectal cancer care that starts with screening. For more information on colorectal cancer and to find out if you should be screened, click here.
Colorectal Multidisciplinary Care Team Conference Schedule:
|1/18/2018||Rathbone Conference Room||7:00 a.m.|
|3/15/2018||Rathbone Conference Room||7:00 a.m.|
|5/17/2018||Rathbone Conference Room||7:00 a.m.|
|9/20/2018||Rathbone Conference Room||7:00 a.m.|
|11/15/2018||Rathbone Conference Room||7:00 a.m.|
RECTAL MULTIDISCIPLINARY TEAM
Treatment outcomes for rectal cancer patients are enhanced when their care is managed by a multidisciplinary team (MDT) care that includes surgeons, pathologists, radiologists and medical and radiation oncologists and other experts. The rectal MDT brings together specialists with different areas of expertise to collaborate and evaluate the optimal level of care for patients based on their disease. This ensures each rectal cancer patient treated at the Cancer Center receives the most individualized, comprehensive and effective treatment plans possible.
For many years in the U.S., there has been tremendous variability in the treatment and outcomes for rectal cancer care. In Europe, hospital clinicians have been improving their outcomes for this disease by working in multidisciplinary teams. In the last decade, there has been a movement to harness this approach in the U.S. in order to improve rectal cancer care, sparking the creation of a new quality improvement initiative, the National Accreditation Program for Rectal Cancer (NAPRC). The program is administered by the American College of Surgeons (ACS) and the Cancer Center in working toward accreditation in 2019.
For more information on the Cancer Center’s rectal cancer treatment program, contact Kelly Finan, MD, MSPH, FACS, FASCRS, chair of the rectal multidisciplinary team.
HEAD & NECK MDC TEAM
The Head and Neck Cancer Multidisciplinary Care Team is a group of experts specializing in the diagnosis, treatment and management of people with cancers of the head and neck. The team, along with other Cancer Center doctors and staff members, are often called on by other head and neck cancer specialists throughout Louisiana to offer insight on difficult cases. Members of the Head and Neck Team use the latest technologies to fight cancer, including the da Vinci® Surgical System, a sophisticated robotic platform designed to enable complex surgery using a minimally invasive approach.
Dr. Daniel Nuss, chair of the Cancer Center’s Head and Neck MDC Team and ranked in the top 1% of doctors according to America’s Top Doctors® for Cancer listing, says that he and his colleagues are concerned about the lack of knowledge on oral, head and neck cancers and feel it is important for everyone to become educated about these diseases. The team’s goal is to help raise awareness of head and neck cancers to create a healthier community.
For more information on head and neck cancers and to find out if you should be screened, click here.
Head & Neck Multidisciplinary Care Team Conference Schedule:
|2/14/2018||Rathbone Conference Room||5:00 p.m.|
|4/18/2018||Rathbone Conference Room||5:00 p.m.|
|6/20/2018||Rathbone Conference Room||5:00 p.m.|
|8/15/2018||Rathbone Conference Room||5:00 p.m.|
|10/17/2018||Rathbone Conference Room||5:00 p.m.|
HEPATOBILIARY/UPPER GI MDC TEAM
Hepatobiliary, or upper gastrointestinal cancers, include esophagus, stomach, pancreas, gallbladder, small intestine, gastrointestinal, liver and intrahepatic bile duct. Diseases that affect the hepatobiliary system, such as cancer, can inhibit the normal functions of digestion, preventing the body from properly absorbing nutrients and processing toxins.
For Physicians: View the Hepatocelluar Carcinoma Clinical Pathways.
Hepatobiliary/Upper GI Multidisciplinary Care Team Conference Schedule:
|1/30/2018||Rathbone Conference Room||4:30 p.m.|
|2/27/2018||Rathbone Conference Room||4:30 p.m.|
|3/27/2018||Rathbone Conference Room||4:30 p.m.|
|4/24/2018||Rathbone Conference Room||4:30 p.m.|
|5/29/2018||Rathbone Conference Room||4:30 p.m.|
|6/26/2018||Rathbone Conference Room||4:30 p.m.|
|8/28/2018||Rathbone Conference Room||4:30 p.m.|
|9/25/2018||Rathbone Conference Room||4:30 p.m.|
|10/30/2018||Rathbone Conference Room||4:30 p.m.|
|11/24/2018||Rathbone Conference Room||4:30 p.m.|
LUNG MDC TEAM
Approximately 219,000 people in the United States are diagnosed with lung cancer every year. The Cancer Center’s Lung Cancer Multidisciplinary Team (MDC) is a group of experts that collaborates to increase the early detection of the disease and ensures best treatment options for patients diagnosed with non-small cell lung cancer, small cell lung cancer and mesothelioma.
Comprised of pulmonologists, thoracic surgeons, medical and radiation oncologists, interventional radiologists, patient navigators, nurses and other ancillary staff, the team focuses on improving patient outcomes and survival through evidenced-based care while monitoring quality to enhance the program’s growth.
The Cancer Center’s Lung MDC Team has developed multiple best practice offerings for patients, including a Lung Cancer Screening Clinic, which offers a low dose CT scan for identifying early stage lung cancers.
- Learn more about if you should be screened for lung cancer.
- The Lung MDC includes a subgroup, the Mesothelioma Specialty Treatment Team, focusing on the diagnosis and treatment of this disease.
- The Cancer Center offers a number of lung cancer clinical trials.
- Learn more about lung cancer.
Lung Multidisciplinary Care Team Conference Schedule:
|2/13/2018||Rathbone Conference Room||12:00 p.m.|
|4/17/2018||Rathbone Conference Room||12:00 p.m.|
|6/19/2018||Rathbone Conference Room||12:00 p.m.|
|8/14/2018||Rathbone Conference Room||12:00 p.m.|
|10/16/2018||Rathbone Conference Room||12:00 p.m.|
MESOTHELIOMA SPECIALTY TREATMENT TEAM
Mesothelioma is a rare, aggressive form of cancer that develops in the lining of the lungs, abdomen or heart. People who have worked with or been exposed to asbestos have the highest risk of developing the disease.
In affiliation with the CVT Surgical Center, the Cancer Center’s Mesothelioma Program offers a comprehensive, multidisciplinary treatment approach consisting of surgeons, medical and radiation oncologists and pulmonologists who collaborate to design an optimal plan of care for patients. The treatment team is supported by a patient navigator who serves as a personal cancer coach and ensures continuity of care at every stage.
For more information, please call (225) 767-6035 or (225) 766-0416.
For Physicians: View the Mesothelioma Clinical Pathways.
SKIN & SOFT TISSUE MDC TEAM
According to the American Cancer Society, approximately 2 million cases of skin cancer will be diagnosed this year. Because of this startling statistic, our Skin and Soft Tissue Cancer Multidisciplinary Care Team (MDC Team), which includes physician experts in all aspects of skin cancer, are collaborating on best practice prevention and treatment of melanoma and nonmelanoma skin cancers. They are also urging greater awareness and education during National Skin Cancer Awareness Month in May and throughout the year by offering basic pointers on how adults and children can protect their skin: stay out of the sun between 10 a.m. and 4 p.m.; use sunscreen with SPF 30 or higher; cover up with long sleeves and a hat; and check your skin once a month for changes.
For more information on skin cancers and to find out if you should be screened, click here.
Skin & Soft Tissue Multidisciplinary Care Team Conference Schedule:
|1/18/2018||Rathbone Conference Room||5:00 p.m.|
|3/15/2018||Rathbone Conference Room||5:30 p.m.|
|5/17/2018||Rathbone Conference Room||5:30 p.m.|
|9/20/2018||Rathbone Conference Room||5:30 p.m.|
|11/15/2018||Rathbone Conference Room||5:30 p.m.|
SARCOMA SPECIALITY TEAM
Sarcoma is an uncommon group of cancers that arise in the bones, and connective tissue such as fat and muscle. Symptoms depend on tumor type and location. They may include a noticeable lump or pain. According to the National Cancer Institute, sarcomas are not common among any age group. In adults, sarcomas are estimated to be about one percent of all cancers, and approximately 12,000 people a year in the U.S. are diagnosed with the disease.
The Cancer Center’s sarcoma team members work together to offer a comprehensive, multidisciplinary treatment approach to patients diagnosed with this rare disease. Team specialists include physicians who focus on musculoskeletal oncology, pathology and surgical, medical and radiation oncology and others who design an optimal plan of care for patients. The team is supported by a navigator who serves as a personal cancer coach and ensures patients are supported throughout their treatment and beyond.
For more information on sarcoma treatment, please contact any of the physicians below.
For Physicians: View the Sarcoma Clinical Pathways
HOUMA LUNG MDC TEAM
Our Lung Cancer Multidisciplinary Care Team is aiming to reduce the number of cancer deaths by providing lung cancer screenings for high-risk individuals. When caught early, about 80 to 90 percent of lung cancer cases are curable, according to the New England Journal of Medicine. The Lung Team is composed of specialists to ensure the highest quality, individualized care for every patient.
For more information on lung cancers and to find out if you should be screened, click here.